Europe Nasal Decongestant Market Industry Analysis By Size, Growth Rate, Trends, Share, Developments, and Regional Outlook

Decongestant produces vasoconstriction within the nasal mucosa through alpha adrenergic receptor activation and hence they are effective in reducing the symptoms of nasal obstruction. However, these agents have no effect on other symptoms like rhinorrhoea, pruritis or sneezing and may be most effective when used in combination with other agents such as antihistamines. There is number of decongestants are available for oral use but most frequently used decongestant is pseudoephedrine. The common side effects of oral decongestant are central nervous system like nervousness, insomnia, irritability and headache.

To know the scope of our report get a sample on https://www.axiommrc.com/request-for-sample/10822-europe-nasal-decongestant-market-report

MARKET DYNAMICS- EUROPE NASAL DECONGESTANT MARKET

The Europe nasal decongestant market is witnessing rapid growth during the forecast period of 2021 to 2027. The nasal decongestant is the monotherapy for the common cold and various other breathing illnesses. The dynamic factors such as rising cases of COVID-19 virus is propelling growth of Europe nasal decongestant market. The rising number of otolaryngology examinations have expanded the awareness of decongestion which is also boosting growth of Europe nasal decongestant market. However, complication related to overuse of nasal sprays is hindering growth of Europe nasal decongestant market.

COVID-19 IMPACT ON EUROPE NASAL DECONGESTANT MARKET

The exclusive COVID-19 impact analysis report by Axiom MRC provides a 3600 analysis of micro and macro-economic factors on the nasal decongestant market. In addition, complete analysis of changes on nasal decongestant expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on Europe economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The healthcare and pharmaceutical companies are going through high pressure for drug innovation to treat coronavirus in patients. The invention of vaccines by key players has lowered the pressure on the pharmaceutical companies to launch drugs for the novel infection. However, key players in nasal decongestant market are rising their R&D efforts. Due to these the nasal decongestant market have experienced positive impact during COVID-19 pandemics.

EUROPE NASAL DECONGESTANT MARKET- SEGMENTAL OVERVIEW

The Europe nasal decongestant market is categorised by product type, application and country.

EUROPE NASAL DECONGESTANT MARKET BY PRODUCT TYPE

Based on product type, the Europe nasal decongestant market is segmented into nasal strips, tablets, spray and capsules. In which sprays segment is also contributing in the growth of Europe nasal decongestant market. The rising number of patients suffering from allergic reactions like cold, congestion, sneezing and runny nose is propelling growth of Europe nasal decongestant market. The surge in the use of nasal sprays for decongestion of nose is also boosting growth of Europe nasal decongestant market. The rising prevalence of allergies is also refuelling growth of Europe nasal decongestant market.

EUROPE NASAL DECONGESTANT MARKET BY APPLICATION 

Based on application, the Europe nasal decongestant is bifurcated into asthma, cold and nasal allergies. In which nasal allergies is also contributing in the growth of Europe nasal decongestant market. Allergic rhinitis occurs seasonally or year-round. Diagnosis of the nasal allergies comprised of the history taking, examination of the nasal passage and sometimes skin testing. The nasal allergies is characterised by the symptoms such as sneezing, runny nose and red nose along with watery and itchy eyes. The growing cases of allergic rhinitis is also boosting growth of Europe nasal decongestant market.

EUROPE NASAL DECONGESTANT MARKET BY COUNTRY

The Europe nasal decongestant is studied for key countries such as United Kingdom, Germany, France, Italy and Spain. The United Kingdom is anticipated to dominate the market in 2020. The rising population prone to various allergies is propelling growth of Europe nasal decongestant market. The rising economic developments is also boosting growth of Europe nasal decongestant market. The growing research and development is also refuelling growth of Europe nasal decongestant market.

KEY PLAYERS IN NASAL DECONGESTANT MARKET

The major key players in nasal decongestant market are 3M, Abbott Laboratories, Adapt Pharma Inc., Aegis Therapeutics Llc, Allergan Plc, Aptargroup Inc., Astrazeneca Plc, Bayer, Becton, Dickinson And Company, Cipla, Glaxosmithkline Plc, Innovus Pharmaceuticals Inc., Johnson & Johnson Services Inc., Meda Pharmaceuticals Inc., Merck & Co., Inc., Mylan N.V, Nastech Pharmaceutical Company Inc., Nidda Healthcare, Novartis Ag, Patrick Parsons, Pfizer Inc., Procter And Gamble, Rugby Laboratories and Sandoz International Gmbh among others.

KEY DEVELOPMENTS IN NASAL DECONGESTANT MARKET

November 2019, Sandoz announced that it has entered into a binding agreement for the planned acquisition of the Japanese business of Aspen Global Incorporated (AGI), a wholly owned subsidiary of Aspen Pharmacare Holdings Limited. Strengthening position in world’s third largest generics market.

June 2019: AptarGroup, Inc. acquired two pharmaceutical services companies, Nanopharm Ltd. and Gateway Analytical LLC. The acquisitions are part of strategy to broaden its portfolio of services which supports pharmaceutical and biotech customers to accelerate their complex product development.

April 2019: Cipla Ltd. acquired 30% Stake in South African's Brandmed For Business Expansion. The Acquisition was carried out to pair the company’s strengths with Brandmed’s innovative, patient-centric approach to healthcare which will enhance Cipla Medpro’s portfolio.

December 2018: Procter & Gamble (P&G) completed the acquisition of Merck’s Consumer Health business. It is intended to improve P&G’s over the counter (OTC) geographic scale brand portfolio and category footprint across 15 markets.

Buy now Europe Nasal Decongestant Market Report https://www.axiommrc.com/buy_now/10822-europe-nasal-decongestant-market-report

About Us:

Axiom Market Research & Consulting™ is a full-service market research and data analytics company providing key market intelligence to global companies to take informed business decisions pertaining to their marketing strategy, investments, new product launches, market competition, consumer or end users, social media trends etc. 

Axiom Market Research & Consulting™ offers market research services such as syndicated market research, custom market research, business consulting, and consumer/end user surveys. Under Business to Consumer (B2C) market research offerings, Axiom MRC assists its clients in finding quantitative information/preferences of its brands and services such as, awareness, usages, satisfaction, tracking, ethnicity etc. Axiom MRC offers data collection services through online surveys, social media, data processing and interpretation.

Axiom MRC with its experienced team of research and data analysts, has delivered more than 5000+ Market Research Projects, 3800+ Data Analytics Projects, 1200+ Business Support Projects and has a 800+ Global Client Base. Axiom Market Research & Consulting™ aims to become the preferred market research and data analytics company by providing key market intelligence solutions for client’s business growth.

Contact Us:

Axiom Market Research & Consulting™

3 Germay Dr. Ste 4 - 4666

Wilmington DE 19804

U.S.:- + 1 (845) 875-9786

U.K.:- + 44 (0) 20 3286 9707

Email: sales@axiommrc.com

Website: https://www.axiommrc.com/

Blog: https://industrywatch24.com/

          https://readbeyondnews.com/

Follow On

LinkedIn: https://www.linkedin.com/company/axiom-market-research-and-consulting/

Twitter:  https://twitter.com/AxiommrcCom

Comments

Post a Comment

Popular posts from this blog

Induced Pluripotent Stem Cells Market is anticipated to grow at a CAGR of 7.32% from 2022 to 2028

Image
Global Induced Pluripotent Stem Cells Market research report provides comprehensive information on the market. It also includes in-depth information about Market #Drivers, Opportunities, Market Restraints, Market Growth #Challenges and Cumulative #Growth Analysis. Moreover, the report also provides an in-depth analysis of the Induced Pluripotent Stem Cells Market by identifying key players. The report also examines the #competitive landscape of the Induced Pluripotent Stem Cells Market industry and analyses its impact on the growth of this market over the next few years. The segmental analysis focuses on revenue and forecast for the period 2019-2028.   Request PDF Sample Copy of Report @ https://www.axiommrc.com/request-for-sample/11226-induced-pluripotent-steam-cells-market-report   Axiom Market Research & Consulting™ added a report on Global Induced Pluripotent Stem Cells Market which includes study on derived cell type, product, process, application, end ...
Read more

Freeze Drying Equipment Market: Growth, Opportunities, and Future Outlook

Freeze Drying Equipment Market is segmented based on type, application, and region. The different types of freeze drying equipment include laboratory, pilot, and industrial-scale equipment. The applications of freeze drying equipment include food processing, pharmaceuticals, biotechnology, and others. The market is dominated by the pharmaceutical and biotechnology segments due to the high demand for freeze-dried drugs and vaccines.   Freeze drying, also known as lyophilization, is a dehydration process used to preserve perishable materials such as food, pharmaceuticals, and biologicals. Freeze drying equipment is used to carry out this process, which involves freezing the material and then removing the ice by sublimation. Freeze drying equipment is an essential tool for industries that require long-term storage of perishable materials. The global freeze drying equipment market is expected to grow at a significant rate in the coming years due to the increasing demand for freeze...
Read more

Future of Europe Infection Surveillance Solutions Market in 2022-2028

Image
Infection surveillance solutions are used to reduce several healthcare associated infections such as pneumonia (eg, ventilator-associated pneumonia [VAP]), bloodstream infection (BSI), urinary tract infection (UTI), and surgical site infection (SSI). It is also used to reduce other infections such as surgical wound infections, respiratory tract infections, and many others. A healthcare-associated infection is an infection whose development is favored by a hospital or other healthcare facilities environment, such as one acquired by a patient during a hospital visit To know the scope of our report get a sample  on https://www.axiommrc.com/request-for-sample/11021-europe-infection-surveillance-solutions-market-report MARKET DYNAMIC- EUROPE INFECTION SURVEILLANCE SOLUTIONS MARKET Primary driving factors such as the vast presence of developing as well as developed economies, increasing funding for improving the healthcare infrastructure and redevelopment of healthcare projects and s...
Read more